N/A N=4 Randomized Double-blind

A Study of Dental Implants Coated With Bone Morphogenetic Protein

Alveolar Ridge Abnormality

Bottom Line

View on ClinicalTrials.gov: NCT00422279 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

May 2015

Primary outcome: Primary: Primary Endpoint Was to Assess Implant Stability of the Implants( 4 Patients in Two Groups With a Total of 8 Implants) at Baseline and After 3 Months of Submerged Healing and After 6 Months of Prosthetic Loading — 4; 4; 4; 3 implants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Nobel Replace Tapered Groovy (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Nobel Biocare
Primary completion: Nov 2009

Outcome Measures

Outcome	Result	p-value
PRIMARY Primary Endpoint Was to Assess Implant Stability of the Implants( 4 Patients in Two Groups With a Total of 8 Implants) at Baseline and After 3 Months of Submerged Healing and After 6 Months of Prosthetic Loading	4; 4; 4; 3; 4; 3	—
SECONDARY Number of Participants Showing Bone Growth With rhBMP-2 (15 and 30 µg Per Implant)	0; 0	—

Summary

The purpose of the study is to evaluate implant stability and stimulate clinically relevant horizontal and vertical new bone formation around Nobel Biocare's Bone Inductive Implant.

Eligibility Criteria

Inclusion Criteria

Above the age of 18 years.
2 teeth or more are missing either upper/lower jaw (Treatment Gp 1)
2 or more teeth require extraction either upper/lower jaw.(Treatment Gp 2)

Exclusion Criteria

Medical risk patients
Smoking.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00422279). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.